We used human PC-3 and DU145 prostate cancer cells to address this question since Huang and colleagues had previously reported that these cells express Fn14 and that TWEAK treatment increases their invasion in Matrigel chamber assays [39]. The gene discussed is TNFRSF12A; the disease is prostate carcinoma.